Overview
46,XY partial gonadal dysgenesis (also known as 46,XY PGD, partial testicular dysgenesis, or ambiguous genitalia due to partial gonadal dysgenesis) is a rare disorder of sex development (DSD) in which individuals have a 46,XY karyotype but their gonads (testes) do not develop fully. Unlike complete gonadal dysgenesis where the testes fail to form entirely, in partial gonadal dysgenesis there is some residual testicular tissue that produces variable amounts of testosterone and anti-Müllerian hormone (AMH). This results in ambiguous genitalia at birth, with features that may range from predominantly female to predominantly male external appearance, depending on the degree of testicular function during fetal development. The condition primarily affects the reproductive and endocrine systems. Key clinical features include ambiguous external genitalia (such as micropenis, hypospadias, bifid scrotum, or clitoromegaly), the possible presence of both Müllerian structures (such as a rudimentary uterus or fallopian tubes) and Wolffian duct derivatives, and dysgenetic gonads that may appear as streak gonads or partially formed testes. Cryptorchidism (undescended testes) is common. Individuals with this condition are at increased risk for gonadal tumors, particularly gonadoblastoma and dysgerminoma, especially if dysgenetic gonadal tissue is retained. Several genes have been implicated in 46,XY partial gonadal dysgenesis, including mutations in SRY, NR5A1 (SF1), DHH, MAP3K1, and other genes involved in testicular determination and differentiation. The inheritance pattern varies depending on the underlying genetic cause. Management is individualized and may include hormone replacement therapy (testosterone or estrogen depending on the sex of rearing), surgical correction of genital ambiguity, gonadectomy to reduce tumor risk in retained dysgenetic gonads, and psychological support. Sex assignment decisions are made collaboratively with families and a multidisciplinary team, taking into account the degree of virilization, potential for fertility, and psychosocial considerations.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for 46,XY partial gonadal dysgenesis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for 46,XY partial gonadal dysgenesis at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to 46,XY partial gonadal dysgenesis.
Community
No community posts yet. Be the first to share your experience with 46,XY partial gonadal dysgenesis.
Start the conversation →Latest news about 46,XY partial gonadal dysgenesis
No recent news articles for 46,XY partial gonadal dysgenesis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about 46,XY partial gonadal dysgenesis
What is 46,XY partial gonadal dysgenesis?
46,XY partial gonadal dysgenesis (also known as 46,XY PGD, partial testicular dysgenesis, or ambiguous genitalia due to partial gonadal dysgenesis) is a rare disorder of sex development (DSD) in which individuals have a 46,XY karyotype but their gonads (testes) do not develop fully. Unlike complete gonadal dysgenesis where the testes fail to form entirely, in partial gonadal dysgenesis there is some residual testicular tissue that produces variable amounts of testosterone and anti-Müllerian hormone (AMH). This results in ambiguous genitalia at birth, with features that may range from predomina
At what age does 46,XY partial gonadal dysgenesis typically begin?
Typical onset of 46,XY partial gonadal dysgenesis is neonatal. Age of onset can vary across affected individuals.
Which specialists treat 46,XY partial gonadal dysgenesis?
1 specialists and care centers treating 46,XY partial gonadal dysgenesis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.